Metoprolol
Dutoprol, Kapspargo, Lopressidone, Lopressor, Metoprolol, Toprol-xl (metoprolol) is a small molecule pharmaceutical. Metoprolol was first approved as Lopressor on 1982-01-01. It is used to treat angina pectoris, atrial fibrillation, atrial flutter, heart failure, and hypertension amongst others in the USA. The pharmaceutical is active against beta-1 adrenergic receptor. In addition, it is known to target beta-2 adrenergic receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| cardiovascular diseases | D002318 |
| signs and symptoms pathological conditions | D013568 |
Trade Name
FDA
EMA
Kapspargo, Lopressor, Metoprolol, Toprol-xl (discontinued: Lopressor, Metoprolol)
CombinationsLopressor, Metoprolol hydrochlorothiazide (discontinued: Dutoprol, Lopressidone, Lopressor, Metoprolol hydrochlorothiazide)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Chlorthalidone
+
Metoprolol tartrate
Metoprolol tartrate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| LOPRESSOR | Validus Pharmaceuticals | N-017963 RX | 1982-01-01 | 2 products, RLD |
Show 1 discontinued
Metoprolol fumarate
Metoprolol succinate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| KAPSPARGO SPRINKLE | Sun Pharmaceuticals | N-210428 RX | 2018-01-26 | 4 products, RLD, RS |
| TOPROL-XL | Toprol Acquisition | N-019962 RX | 1992-01-10 | 4 products, RLD, RS |
Hydrochlorothiazide
+
Metoprolol tartrate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| LOPRESSOR HCT | Validus Pharmaceuticals | N-018303 RX | 1984-12-31 | 1 products, RLD |
Show 1 discontinued
Hydrochlorothiazide
+
Metoprolol succinate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| DUTOPROL | Concordia Laboratories | N-021956 DISCN | 2006-08-28 | 3 products, RLD |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| hypertensolol | unapproved drug other | 2011-08-01 |
| kapspargo | New Drug Application | 2023-04-12 |
| lopressor | New Drug Application | 2023-09-14 |
| lopressor hct | New Drug Application | 2023-09-13 |
| metoprolol | ANDA | 2024-05-30 |
| metoprolol succinate | ANDA | 2025-01-14 |
| metoprolol succinate er | ANDA | 2024-04-11 |
| metoprolol succinate metoprolol succinate er | ANDA | 2024-01-10 |
| metoprolol succinate metoprolol tartrate | ANDA | 2024-01-09 |
| metoprolol tartate | ANDA | 2015-04-01 |
Show 7 more
Indications
FDA
EMA
Show 3 more
Agency Specific
FDA
EMA
No data
ATC Codes
C: Cardiovascular system drugs
— C07: Beta-adrenergic blocking agents
— C07A: Beta blocking agents
— C07AB: Beta blocking agents, selective
— C07AB02: Metoprolol
— C07B: Beta blocking agents and thiazides
— C07BB: Beta blocking agents, selective, and thiazides
— C07BB02: Metoprolol and thiazides
— C07BB52: Metoprolol and thiazides, combinations
— C07C: Beta blocking agents and other diuretics
— C07CB: Beta blocking agents, selective, and other diuretics
— C07CB02: Metoprolol and other diuretics
— C07F: Beta blocking agents, other combinations
— C07FB: Beta blocking agents and calcium channel blockers
— C07FB02: Metoprolol and felodipine
— C07FB13: Metoprolol and amlodipine
— C07FX: Beta blocking agents, other combinations
— C07FX03: Metoprolol and acetylsalicylic acid
— C07FX05: Metoprolol and ivabradine
HCPCS
No data
Clinical
Clinical Trials
318 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | D006973 | EFO_0000537 | I10 | 3 | 9 | 21 | 33 | 16 | 77 |
| Heart failure | D006333 | HP_0001635 | I50 | 1 | 5 | 7 | 12 | 12 | 36 |
| Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | 2 | 2 | 5 | 10 | 11 | 29 |
| Coronary artery disease | D003324 | — | I25.1 | 1 | — | — | 5 | 12 | 18 |
| Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 1 | 2 | 2 | 8 | 1 | 13 |
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | — | 3 | 10 | 13 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | 1 | 2 | 2 | 7 | 2 | 13 |
| Cardiomyopathies | D009202 | EFO_0000318 | I42 | 1 | 4 | 4 | 5 | 1 | 13 |
| Coronary disease | D003327 | — | — | — | — | 1 | 4 | 7 | 12 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 3 | 1 | 1 | 5 | 1 | 11 |
Show 83 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | 1 | 3 | — | 1 | 5 |
| Chronic renal insufficiency | D051436 | — | N18 | 1 | 2 | 1 | — | 1 | 4 |
| Burns | D002056 | — | T30.0 | — | 4 | 4 | — | — | 4 |
| Ventricular tachycardia | D017180 | — | I47.2 | — | 2 | 1 | — | 2 | 4 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | 1 | — | 1 | 3 |
| Renal insufficiency | D051437 | HP_0000083 | N19 | — | 1 | 1 | — | 1 | 3 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | 1 | 1 | — | 1 | 3 |
| Fibrosis | D005355 | — | — | — | 1 | 1 | — | 1 | 3 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | — | 1 | — | 2 | 3 |
| Lung neoplasms | D008175 | HP_0100526 | C34.90 | — | — | 2 | — | — | 2 |
Show 29 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 19 | 1 | — | — | — | 20 |
| Tachycardia | D013610 | HP_0001649 | R00.0 | 1 | 2 | — | — | 4 | 7 |
| Atopic dermatitis | D003876 | EFO_0000274 | L20 | 4 | 1 | — | — | — | 5 |
| Dermatitis | D003872 | HP_0011123 | L30.9 | 4 | 1 | — | — | — | 5 |
| Eczema | D004485 | HP_0000964 | L30.9 | 3 | 1 | — | — | — | 4 |
| Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | 2 | — | — | — | 2 |
| Neoplasms | D009369 | — | C80 | 2 | 1 | — | — | — | 2 |
| Postural orthostatic tachycardia syndrome | D054972 | — | G90.A | — | 1 | — | — | 1 | 2 |
| Wounds and injuries | D014947 | — | T14.8 | — | 2 | — | — | — | 2 |
| Prader-willi syndrome | D011218 | Orphanet_739 | Q87.11 | — | 2 | — | — | — | 2 |
Show 19 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pharmacokinetics | D010599 | — | — | 2 | — | — | — | 1 | 3 |
| Drug interactions | D004347 | — | — | 2 | — | — | — | 1 | 3 |
| Covid-19 | D000086382 | — | — | 1 | — | — | — | 1 | 2 |
| Pure autonomic failure | D054970 | — | — | 1 | — | — | — | 1 | 2 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 2 | — | — | — | — | 2 |
| Fasting | D005215 | EFO_0002756 | — | 2 | — | — | — | — | 2 |
| Malaria | D008288 | EFO_0001068 | B54 | 1 | — | — | — | — | 1 |
| Hepatitis c | D006526 | — | B19.2 | 1 | — | — | — | — | 1 |
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | 1 | — | — | — | — | 1 |
| Crohn disease | D003424 | EFO_0000384 | K50 | 1 | — | — | — | — | 1 |
Show 8 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Percutaneous coronary intervention | D062645 | — | — | — | — | — | — | 2 | 2 |
| Kidney transplantation | D016030 | — | — | — | — | — | — | 2 | 2 |
| Cerebral hemorrhage | D002543 | — | — | — | — | — | — | 2 | 2 |
| Chest pain | D002637 | HP_0100749 | R07.9 | — | — | — | — | 2 | 2 |
| Coronary occlusion | D054059 | — | I21 | — | — | — | — | 1 | 1 |
| Drug-eluting stents | D054855 | — | — | — | — | — | — | 1 | 1 |
| Postoperative nausea and vomiting | D020250 | EFO_0004888 | — | — | — | — | — | 1 | 1 |
| Vomiting | D014839 | HP_0002013 | R11.1 | — | — | — | — | 1 | 1 |
| Nausea | D009325 | HP_0002018 | R11.0 | — | — | — | — | 1 | 1 |
| Postoperative pain | D010149 | — | G89.18 | — | — | — | — | 1 | 1 |
Show 13 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Metoprolol |
| INN | metoprolol |
| Description | Metoprolol is a propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1. It has a role as a beta-adrenergic antagonist, an antihypertensive agent, a xenobiotic, an environmental contaminant and a geroprotector. It is a propanolamine, an aromatic ether, a secondary alcohol and a secondary amino compound. |
| Classification | Small molecule |
| Drug class | beta-blockers (propranolol type) |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | COCCc1ccc(OCC(O)CNC(C)C)cc1 |
Identifiers
| PDB | — |
| CAS-ID | 37350-58-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL13 |
| ChEBI ID | 6904 |
| PubChem CID | 4171 |
| DrugBank | DB00264 |
| UNII ID | GEB06NHM23 (ChemIDplus, GSRS) |
Target
Agency Approved
Alternate
ADRB2
ADRB2
Organism
Homo sapiens
Gene name
ADRB2
Gene synonyms
ADRB2R, B2AR
NCBI Gene ID
Protein name
beta-2 adrenergic receptor
Protein synonyms
adrenergic, beta-2-, receptor, surface, adrenoceptor beta 2 surface, Beta-2 adrenoceptor, Beta-2 adrenoreceptor, catecholamine receptor
Uniprot ID
Mouse ortholog
Adrb2 (11555)
beta-2 adrenergic receptor (Q8BH38)
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Metoprolol
+
Hydrochlorothiazide
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Metoprolol
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 25,407 documents
View more details
Safety
Black-box Warning
Black-box warning for: Hypertensolol, Metoprolol succinate metoprolol succinate er
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
55,856 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use